LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

Search

Pluristem Therapeutics Inc

Geschlossen

4.83 -6.03

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.57

Max

5.33

Dividenden

By Dow Jones

Nächstes Ergebnis

14. Mai 2025

Pluristem Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Mai 2025, 23:20 UTC

Ergebnisse

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13. Mai 2025, 23:48 UTC

Market Talk

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13. Mai 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13. Mai 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13. Mai 2025, 23:24 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

13. Mai 2025, 23:24 UTC

Market Talk
Ergebnisse

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13. Mai 2025, 22:58 UTC

Ergebnisse

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13. Mai 2025, 22:58 UTC

Ergebnisse

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13. Mai 2025, 22:58 UTC

Ergebnisse

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13. Mai 2025, 22:58 UTC

Ergebnisse

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13. Mai 2025, 22:38 UTC

Ergebnisse

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13. Mai 2025, 22:38 UTC

Ergebnisse

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13. Mai 2025, 22:37 UTC

Ergebnisse

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13. Mai 2025, 22:36 UTC

Ergebnisse

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13. Mai 2025, 22:35 UTC

Ergebnisse

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13. Mai 2025, 22:34 UTC

Ergebnisse

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13. Mai 2025, 22:33 UTC

Ergebnisse

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13. Mai 2025, 22:33 UTC

Ergebnisse

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13. Mai 2025, 22:33 UTC

Ergebnisse

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13. Mai 2025, 22:30 UTC

Ergebnisse

Aristocrat Interim Dividend 44 Australian Cents/Share

13. Mai 2025, 22:30 UTC

Ergebnisse

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13. Mai 2025, 22:29 UTC

Ergebnisse

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13. Mai 2025, 22:28 UTC

Ergebnisse

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13. Mai 2025, 21:15 UTC

Ergebnisse

Nu Holdings 1Q Rev $3.2B >NU

13. Mai 2025, 21:03 UTC

Top News

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13. Mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

13. Mai 2025, 20:32 UTC

Ergebnisse

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13. Mai 2025, 20:31 UTC

Ergebnisse

Alcon 1Q Sales $2.45B >ALC.EB

13. Mai 2025, 20:30 UTC

Ergebnisse

Alcon 1Q Rev $2.47B >ALC.EB

13. Mai 2025, 20:30 UTC

Ergebnisse

Alcon 1Q EPS 70c >ALC.EB

Peer-Vergleich

Kursveränderung

Pluristem Therapeutics Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Finanzen

$